Table 2 Clinical and treatment related characteristics among children living with HIV at Debre Tabor and university of Gondar compressive specialized hospitals, Northwest, Ethiopia 2020 (n = 357)
Exposure variable | Responses | Frequency (n = 357) | Percent (%) |
|---|---|---|---|
Weight for height | Normal | 175 | 49.0 |
Underweight | 182 | 59.1 | |
Height for age | Normal | 211 | 59.1 |
Stunted | 146 | 40.9 | |
CD4 counts or % | Below threshold | 70 | 19.6 |
Above threshold | 287 | 80.4 | |
WHO stages | Stage I&II | 244 | 68.3 |
Stage III&IV | 111 | 31.1 | |
Hx of OIs | Yes | 181 | 50.7 |
No | 176 | 49.3 | |
Regimen at baseline | AZT-based | 309 | 86.6 |
d4T-based | 48 | 13.4 | |
Cotrimoxazole preventive therapy (CPT) | Yes | 291 | 81.5 |
No | 66 | 18.5 | |
Isoniazid preventive therapy (IPT) | Yes | 109 | 30.5 |
No | 248 | 69.5 | |
ART adherence | Good | 278 | 77.9 |
Fair | 31 | 8.7 | |
Treatment failure | Poor | 48 | 13.4 |
Yes | 36 | 10.1 | |
TB status | No | 321 | 89.9 |
Yes | 41 | 11.5 | |
ART duration | No | 316 | 88.5 |
< =5 years | 199 | 55.7 | |
Follow-up status Anemia | >  5 years | 158 | 44.3 |
Yes | 58 | 16.2 |